Abstract
Gabapentin (GBP), one of the newer antiepileptic drugs (AEDs), is a structural analogue of gamma-aminobutyric acid (GABA), initially approved for add-on treatment of partial seizures in patients 12 years and older and now widely used also in younger patients. Recent studies demonstrated its efficacy not only as adjunctive therapy but also as monotherapy for patients with partial seizures. GBP has an extremely low propensity to cause drug interactions and is well tolerated. The main adverse effects reported are behavioral disorders, such as hostility and mood swings. Recent data, showing increased GBP clearance in children, indicate the potential need for higher doses in young patients. The goal of seizure control in pediatric patients with epilepsy must be balanced against the long-term effects of AEDs on brain function and development. The anticonvulsant action and the long-term effects of GBP on learning, memory and behavior were investigated in studies on immature animals using models of temporal lobe epilepsy and status epilepticus (SE). These data demonstrated that acute administration of a single dose increases the seizure threshold at all ages studied, while chronic treatment following SE reduces spontaneous seizure frequency and cell damage and has no long-term adverse consequences on cognitive processes during development.
Keywords: gabapentin, epilepsy, antiepileptic drugs, kainic acid, flurothyl, seizures, immature brain
Current Neuropharmacology
Title: Anticonvulsant Action and Long-term Effects of Gabapentin
Volume: 1 Issue: 3
Author(s): M. R. Cilio
Affiliation:
Keywords: gabapentin, epilepsy, antiepileptic drugs, kainic acid, flurothyl, seizures, immature brain
Abstract: Gabapentin (GBP), one of the newer antiepileptic drugs (AEDs), is a structural analogue of gamma-aminobutyric acid (GABA), initially approved for add-on treatment of partial seizures in patients 12 years and older and now widely used also in younger patients. Recent studies demonstrated its efficacy not only as adjunctive therapy but also as monotherapy for patients with partial seizures. GBP has an extremely low propensity to cause drug interactions and is well tolerated. The main adverse effects reported are behavioral disorders, such as hostility and mood swings. Recent data, showing increased GBP clearance in children, indicate the potential need for higher doses in young patients. The goal of seizure control in pediatric patients with epilepsy must be balanced against the long-term effects of AEDs on brain function and development. The anticonvulsant action and the long-term effects of GBP on learning, memory and behavior were investigated in studies on immature animals using models of temporal lobe epilepsy and status epilepticus (SE). These data demonstrated that acute administration of a single dose increases the seizure threshold at all ages studied, while chronic treatment following SE reduces spontaneous seizure frequency and cell damage and has no long-term adverse consequences on cognitive processes during development.
Export Options
About this article
Cite this article as:
Cilio R. M., Anticonvulsant Action and Long-term Effects of Gabapentin, Current Neuropharmacology 2003; 1 (3) . https://dx.doi.org/10.2174/1570159033477099
DOI https://dx.doi.org/10.2174/1570159033477099 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry A Novel Efficient Machine Learning Approach for Multiclass Classification of EEG Signal
Recent Patents on Computer Science Adenosine Dysfunction in Epilepsy and Associated Comorbidities
Current Drug Targets Vital Elements of the Wnt-Frizzled Signaling Pathway in the Nervous System
Current Neurovascular Research Innovation in Contrast Agents for Magnetic Resonance Imaging
Current Medical Imaging An Ion Channel Chip for Diagnosis and Prognosis of Autoimmune Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Neuroinflammation, Diabetes and COVID-19: Perspectives Coming from Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Synthesis and Evaluation of N-substituted (Z)-5-(Benzo[d][1,3]dioxol-5- ylmethylene)-2-Thioxothiazolidin-4-one Derivatives and 5-Substituted- Thioxothiazolidindione Derivatives as Potent Anticonvulsant Agents
CNS & Neurological Disorders - Drug Targets Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease
Central Nervous System Agents in Medicinal Chemistry The Role of Melatonin in Rheumatic Diseases
Infectious Disorders - Drug Targets Rapid Quantification of Neurons and Stem/Progenitor Cells in the Adult Mouse Brain by Flow Cytometry
Letters in Drug Design & Discovery On the Discovery and Development of CFTR Chloride Channel Activators
Current Pharmaceutical Design Pharmacokinetics and Metabolic Drug Interactions
Current Clinical Pharmacology Neuroprotection for Amyotrophic Lateral Sclerosis: Role of Stem Cells, Growth Factors, and Gene Therapy
Central Nervous System Agents in Medicinal Chemistry Nanotubes at Neural and Immune Synapses
Current Medicinal Chemistry An Overview of the Selectivity and Efficiency of the Bacterial Carbonic Anhydrase Inhibitors
Current Medicinal Chemistry Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology
Current Neuropharmacology Curcumin as an Adjuvant to Breast Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Nanostructures and Niosomes: A Quantum Leap in Clotrimazole Therapeutics
Current Drug Therapy Cerebellar Hemangioblastomas in a High-risk Pregnancy: A Case Report and Review of Literature
Current Medical Imaging